Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003219 · ClinicalTrials.gov registry record · Phase 2
Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00003219: Completed Phase 2 study, sponsored by University of Wisconsin, Madison.
NCT00003219 is a Phase 2 study that has completed, run by University of Wisconsin, Madison. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003219, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of perillyl alcohol in treating patients with metastatic breast cancer that has not responded to previous chemotherapy.
Interventions
- DRUG perillyl alcohol
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-05 |
| Est. Completion | 1998-05 |
| Phase | Phase 2 |
What the finished NCT00003219 record still lists
NCT00003219 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which perillyl alcohol is the first listed.
NCT00003219 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003219 about?
NCT00003219 is a clinical study titled "Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of perillyl alcohol in treating patients with metastatic breast cancer that has not responded to previous chemotherapy.
What is the current status of trial NCT00003219?
This trial is currently completed. It is a Phase 2 study. The study started on 1998-05. Estimated completion is 1998-05.
What interventions are being tested in trial NCT00003219?
The interventions under investigation include: perillyl alcohol (DRUG).
Who is sponsoring clinical trial NCT00003219?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia